6533b85ffe1ef96bd12c271b

RESEARCH PRODUCT

Gold(I) compounds with lansoprazole-type ligands

Antonio ZuccaAngela CasiniMaria Agostina CinelluFabio CoccoE. F. J. JanssenE. HemeltBenoît BertrandBenoît BertrandM. Serratice

subject

PharmacologyStereochemistryOrganic ChemistryLansoprazolePharmaceutical ScienceANTIPROLIFERATIVE PROPERTIESSERIESBiochemistryTUMORSIn vitroPROTON-PUMP INHIBITORSchemistry.chemical_compoundchemistryCHEMISTRYTARGETSDrug DiscoverymedicineMolecular MedicineImidazoleSOLUTION BEHAVIORCOMPLEXESAGENTSHuman cancerRESISTANCEmedicine.drug

description

A number of gold(I) complexes containing the proton pump inhibitor (PPI) lansoprazole and its reduced precursor 2-((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methylthio)-1H-benzo[d]imidazole have been synthesized and their biological effects have been evaluated in human cancer and nontumorigenic cells in vitro. The lansoprazole-based compounds appear to act through a V-H+-ATPase-mediated mechanism.

10.1039/c4md00241ehttps://doi.org/10.1039/c4md00241e